NCT02046070View on ClinicalTrials.gov

Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

March 5, 2014

Primary Completion Date

June 29, 2018

Study Completion Date

June 29, 2018

Conditions
Multiple Myeloma
Interventions
DRUG

Cyclophosphamide

Cyclophosphamide tablets

DRUG

Ixazomib

Ixazomib capsules

DRUG

Dexamethasone

Dexamethasone tablets

Trial Locations (24)

Unknown

Hazard

Boston

Rochester

St Louis

New Brunswick

Rochester

Camperdown

Concord

Waratah

Adelaide

Heidelberg

Melbourne

Athens

Athens

Pátrai

Thessaloniki

Lublin

Warsaw

Chorzów

Gdansk

Lodz

Helsingborg

Stockholm

Lund

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY